| Symbol |
MLCK |
| Full Name |
Myosin light chain kinase |
| Chromosome |
3p21.31 |
| NCBI Gene |
3371 |
| Ensembl |
ENSG00000139792 |
| OMIM |
600922 |
| UniProt |
Q9Y463 |
| Gene Type |
Protein coding |
| Protein Class |
Serine/threonine protein kinase |
| Expression |
Brain (cerebellum), Smooth muscle, Heart |
MLCK (Myosin Light Chain Kinase, encoded by the MYLK gene) is a calcium/calmodulin-dependent serine/threonine kinase that plays essential roles in regulating myosin II activity, cytoskeletal dynamics, and cell contractility. While historically studied primarily in smooth muscle cells where it controls muscle contraction, MLCK has emerged as an important regulator of neuronal functions including dendritic spine morphology, synaptic plasticity, and axon guidance 1. The gene encodes a large protein with multiple functional domains that enable its roles in both peripheral and central nervous system tissues.
In the brain, MLCK is particularly enriched in the cerebellum where it participates in Purkinje cell function and synaptic plasticity. Its involvement in neuronal morphology and signaling pathways relevant to neurodegenerative diseases, particularly Alzheimer's disease, has made it a gene of increasing interest in neurobiology research 2.
| Property |
Value |
| Official Symbol |
MLCK (MYLK) |
| Full Name |
Myosin light chain kinase |
| Gene ID |
3371 |
| Chromosomal Location |
3p21.31 |
| Ensembl ID |
ENSG00000139792 |
| UniProt ID |
Q9Y463 |
| OMIM |
600922 |
| Gene Type |
Protein coding |
| Protein Class |
Serine/threonine protein kinase |
| Alias Names |
MYLK, MLCK1, smMLCK |
MLCK is a large multi-domain protein (~220 kDa for the smooth muscle isoform) with distinct functional regions:
- Kinase Domain: The C-terminal catalytic domain phosphorylates myosin light chains
- Calmodulin-Binding Domain: Auto-inhibitory region that binds calmodulin in calcium-dependent manner
- Actin-Binding Domain: N-terminal region mediating interaction with actin filaments
- Telethonin-Binding Site: Specific interaction site in skeletal muscle isoforms
MLCK catalyzes the phosphorylation of the regulatory light chain of myosin II:
Reaction: ATP + Myosin Light Chain → ADP + Phospho-Myosin Light Chain
Substrate: Myosin regulatory light chain (MLC20, encoded by MYL9)
Regulation:
- Calcium/calmodulin: Primary activator
- cAMP-dependent protein kinase (PKA): Phosphorylation inhibits activity
- Rho-associated kinase (ROCK): Phosphorylates and activates MLCK
- Phosphatases: Dephosphorylation reverses activation
MLCK integrates with multiple signaling pathways:
flowchart TD
A["Ca²⁺/Calmodulin"] --> B["MLCK Activation"]
B --> C["MLC Phosphorylation"]
C --> D["Myosin ATPase Activity"]
D --> E["Actin-Myosin Contraction"]
F["ROCK"] -->|"Phosphorylation"| B
G["PKA"] -->|"Inhibition"| B
E --> H["Cell Contraction/Migration"]
E --> I["Spine Morphology"]
E --> J["Axon Guidance"]
MLCK shows distinct expression patterns across tissues:
| Tissue |
Expression Level |
Isoform |
| Smooth muscle |
Very high |
smMLCK |
| Heart |
Moderate |
cardiac MLCK |
| Brain |
Moderate-low |
neuronal MLCK |
| Skeletal muscle |
Low |
skMLCK |
| Endothelium |
Moderate |
eMLCK |
Within the central nervous system:
- Cerebellum: Highest expression, particularly in Purkinje cells
- Cerebral cortex: Lower expression in pyramidal neurons
- Hippocampus: Expression in CA1 pyramidal cells
- Axon tracts: Associated with growth cones during development
The classical function of MLCK in smooth muscle:
- Contraction: Phosphorylates MLC20 to enable actin-myosin interaction
- Maintenance of Tone: Sustained phosphorylation for vascular tone
- Regulation: Modulated by calcium, catecholamines, and other signals
MLCK has several important neuronal functions:
Dendritic Spine Morphology:
- Regulates spine shape and size
- Controls actin cytoskeleton in postsynaptic densities
- Affects synaptic stability and plasticity 3
Synaptic Plasticity:
- Involved in long-term potentiation (LTP)
- Modulates AMPA receptor trafficking
- Contributes to dendritic spine enlargement during LTP
Axon Guidance:
- Regulates growth cone dynamics
- Controls cytoskeletal remodeling in developing neurons
- Guides axonal pathfinding
Cellular Transport:
- Involved in vesicle transport along axons
- Regulates organelle movement
MLCK is implicated in Alzheimer's disease through multiple mechanisms:
Synaptic Dysfunction:
- Altered MLCK activity affects spine plasticity
- Contributes to synaptic loss and memory impairment
- Links to amyloid-beta effects on neuronal morphology 2
Tau Pathology:
- MLCK may be affected by tau phosphorylation changes
- Dysregulated kinase/phosphatase balance impacts MLCK
Therapeutic Potential:
- MLCK inhibitors as potential AD therapeutics
- Targeting spine dynamics to preserve synaptic function
MLCK involvement in Parkinson's disease:
- Dopaminergic Neurons: MLCK in axon guidance and survival
- α-Synuclein Pathology: Effects on cytoskeletal integrity
- Potential for Neuroprotection: Modulating MLCK activity
¶ Stroke and Ischemia
MLCK plays a significant role in stroke pathophysiology:
- Vascular Tone: MLCK in cerebral artery contraction
- Blood-Brain Barrier: Disruption via endothelial MLCK
- Ischemic Damage: Role in post-ischemic hypoperfusion
- Vascular Dementia: MLCK in cerebrovascular dysfunction
- Traumatic Brain Injury: Altered MLCK in axonal damage
- Epilepsy: MLCK in neuronal hyperexcitability
¶ Pharmacology and Therapeutics
Several compounds inhibit MLCK:
| Compound |
Specificity |
Stage |
| ML-7 |
MLCK (Ki = 0.3 μM) |
Research |
| ML-9 |
MLCK and others |
Research |
| Wortmannin |
PI3K >> MLCK |
Research |
| Y-27632 |
ROCK (related) |
Clinical |
Research Applications:
- Studying MLCK function in vitro
- Animal models of disease
- Exploring therapeutic potential
Challenges in targeting MLCK:
- Isoform Specificity: Multiple isoforms limit selectivity
- Peripheral Effects: Smooth muscle effects cause side effects
- Blood-Brain Barrier: CNS delivery challenges
Potential Approaches:
- Brain-penetrant MLCK modulators
- Targeting neuronal isoforms specifically
- Indirect modulation through upstream pathways
Key experimental approaches:
- Biochemistry: Kinase assays, Western blot
- Cell Biology: Immunofluorescence, live cell imaging
- Genetics: siRNA, CRISPR knockouts
- Electrophysiology: Patch clamp recordings
- Animal Models: Transgenic and knockout mice
- Cell Lines: Vascular smooth muscle cells, neurons
- Primary Cells: Hippocampal neurons, cortical neurons
- Animal Models: Mlck knockout mice, transgenic models
¶ Genetics and Variants
MYLK variants identified:
| Variant Type |
Examples |
Clinical Significance |
| Common SNPs |
rs2717154, rs3781913 |
May affect expression |
| Rare variants |
Various |
Under investigation |
- Limited direct data on MLCK variants in neurodegeneration
- Expression studies show altered MLCK in disease states
- Further research needed on genetic contributors
¶ Interactions and Pathways
MLCK interacts with:
- Myosin: Direct phosphorylation target
- Calmodulin: Calcium-dependent activation
- Actin: Cytoskeletal anchoring
- Telethonin: Skeletal muscle-specific interaction
MLCK in cellular signaling:
- Calcium Signaling: Upstream of MLCK activation
- Rho/ROCK Pathway: Modulates MLCK activity
- cAMP/PKA: Negative regulation
- MAPK Cascades: Cross-talk with MLCK signaling
Mlck-deficient mice:
- Smooth Muscle: Reduced contractility
- Vascular: Hypotension in some models
- Neuronal: Learning and memory deficits
- Embryonic: Some lethality depending on model
MLCK in:
- Stroke Models: MLCK inhibition is protective
- AD Models: MLCK modulation affects pathology
- Trauma Models: Role in secondary damage
- What is the precise role of neuronal MLCK in AD?
- Can brain-penetrant MLCK inhibitors be developed?
- What determines isoform-specific functions?
- How does MLCK interact with other cytoskeletal proteins?
- Single-cell Analysis: Understanding MLCK in specific neuron types
- Structural Studies: MLCK structure for drug design
- Therapeutic Development: Moving toward clinical application
- Biomarkers: MLCK as a disease marker
MLCK is a versatile kinase with important functions in both peripheral tissues and the central nervous system. Its roles in regulating cytoskeletal dynamics, synaptic plasticity, and cell contractility make it relevant to multiple aspects of neurodegenerative diseases. While therapeutic targeting of MLCK faces challenges, ongoing research continues to illuminate its functions and potential therapeutic applications.
Key points:
- MLCK is a calcium/calmodulin-dependent kinase regulating myosin light chain phosphorylation
- In neurons, MLCK controls dendritic spine morphology and synaptic plasticity
- MLCK is implicated in Alzheimer's disease through synaptic dysfunction
- MLCK inhibitors show potential in stroke and vascular dementia
- Brain-penetrant MLCK modulators remain an unmet therapeutic need
The continued study of MLCK in neurobiology will advance our understanding of synaptic function and may lead to novel therapeutic approaches for neurodegenerative diseases.
The role of MLCK in synaptic dysfunction makes it a potential therapeutic target for AD:
Strategy 1: Synaptic Protection
- MLCK inhibitors could preserve dendritic spine integrity
- Prevent amyloid-beta-induced spine loss
- Maintain synaptic plasticity
Strategy 2: Tau Phosphorylation Modulation
- MLCK interacts with tau phosphorylation pathways
- Modulating MLCK may affect tau pathology
¶ Stroke and Cerebrovascular Disease
MLCK inhibitors have shown promise in stroke:
Preclinical Results:
- Reduced infarct size in animal models
- Improved cerebral blood flow
- Reduced blood-brain barrier disruption
Clinical Potential:
- Acute stroke treatment
- Hemorrhagic stroke management
- Vascular cognitive impairment
Selectivity Issues:
- Multiple isoforms (smooth muscle, neuronal, endothelial)
- Off-target effects on related kinases
- Compound specificity limitations
Delivery Challenges:
- Blood-brain barrier penetration
- Targeting neuronal vs. peripheral MLCK
- Achieving sufficient brain concentrations
Safety Concerns:
- Cardiovascular effects (blood pressure)
- Smooth muscle dysfunction
- Gastrointestinal effects
Biochemical Methods:
- In vitro kinase assays using recombinant MLCK
- Phospho-MLC20 antibody detection
- Calmodulin binding assays
Cellular Approaches:
- Phospho-MLC immunofluorescence
- Live cell FRET sensors
- Co-immunoprecipitation studies
Live Cell Imaging:
- GFP-MLCK fusion proteins
- Fluorescence resonance energy transfer (FRET)
- Total internal reflection fluorescence (TIRF)
Fixed Tissue:
- Immunohistochemistry
- Electron microscopy
- Super-resolution microscopy
| Species |
Homolog |
Identity |
| Human |
MLCK (MYLK) |
Reference |
| Mouse |
Mylk |
96% |
| Rat |
Mylk |
95% |
| Zebrafish |
mylk |
75% |
| Drosophila |
mlck |
55% |
The high conservation indicates essential functions in muscle and neuronal function across species.
Priority areas for MLCK-targeted therapy:
- Brain-Penetrant Inhibitors: Developing CNS-selective MLCK inhibitors
- Allosteric Modulators: Targeting regulatory domains for selectivity
- Prodrug Strategies: Improving brain delivery
- What are the precise downstream effectors of neuronal MLCK?
- How does MLCK integrate with other synaptic signaling pathways?
- What determines isoform-specific functions in different cell types?
- Can MLCK modulation restore synaptic function in disease models?
Emerging technologies to study MLCK:
- Single-cell RNA-seq: Characterizing MLCK expression in specific neuronal populations
- Spatial transcriptomics: Mapping MLCK in brain regions
- Proteomics: Identifying MLCK interactome in neurons
Novel approaches to targeting MLCK:
- Gene Therapy: Viral vector delivery of MLCK modulators
- Antibody-Based Therapy: Targeting specific isoforms
- Combination Therapy: MLCK inhibition with other interventions
MLCK as a potential biomarker:
- Cerebrospinal Fluid: MLCK levels as neuroinflammation marker
- Blood-Brain Barrier: MLCK in endothelial cells as BBB integrity marker
- Imaging: PET ligands for MLCK (future development)